Recombination favors the evolution of drug resistance in HIV-1 during antiretroviral therapy

Antonio Carvajal‐Rodríguez; Keith A. Crandall; David Posada

doi:10.1016/j.meegid.2007.02.001

Related publications

Article2001

Prevalence of Genotypic Resistance among Antiretroviral Drug-Naive HIV-1-Infected Patients in Belgium

Kristien Van Vaerenbergh, Laurent Debaisieux, Nancy De Cabooter, Cathérine Declercq, K. Desmet, Katrien Fransen, Bart Maes, D. Marissens, Katherine M. Miller, Gaëtan Muyldermans, S Sprecher, Lieven Stuyver, D. Vaira, Chris Verhofstede, Georges Zissis, Marc Van Ranst, De Clercq Erik, Jan Desmyter, Anne‐Mieke Vandamme

Article1998

Maintenance Antiretroviral Therapies in HIV-Infected Subjects with Undetectable Plasma HIV RNA after Triple-Drug Therapy

Diane V. Havlir, Ian C. Marschner, Martin Hirsch, Ann C. Collier, Pablo Tebas, Roland L. Bassett, John P A Ioannidis, M. K. Holohan, Randi Y. Leavitt, Gloria S. Boone, Douglas D. Richman

Article2001

HIV-1 Integration as a Target for Antiretroviral Therapy: A Review

Wim Pluymers, De Clercq Erik, Zeger Debyser

Article1998

Evolution of HIV drug Resistance in Zidovudine/Zalcitabine- and Zidovudine/ Didanosine-Experienced Patients Receiving Lamivudine-Containing Combination Therapy

Jean‐Claude Schmit, Javier Martínez‐Picado, Lı́dia Ruiz, Cristina Jural, Kristel Van Laethem, Cecilia Cabrera, A Campayo Ibáñez, Teresa Puig, Myriam Witvrouw, Jan Desmyter, De Clercq Erik, Bonaventura Clotet, Anne‐Mieke Vandamme

Article2011

Monitoring of lipodystrophic and metabolic abnormalities in HIV-1 infected children on antiretroviral therapy

Vana Spoulou, Christina Kanaka‐Gantenbein, Irini Bathrellou, Stefano Mora, Glyceria Mostrou, Labros S. Sidossis, George Chrousos, Maria Theodoridou